{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T19:38:08Z","timestamp":1773085088318,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"27-28","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.vaccine.2008.04.058","type":"journal-article","created":{"date-parts":[[2008,5,13]],"date-time":"2008-05-13T08:17:54Z","timestamp":1210666674000},"page":"3389-3394","source":"Crossref","is-referenced-by-count":46,"title":["Poly(propyleneimine) dendrimer and dendrosome mediated genetic immunization against hepatitis B"],"prefix":"10.1016","volume":"26","author":[{"given":"Tathagata","family":"Dutta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minakshi","family":"Garg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narendra K.","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2008.04.058_bib1","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1126\/science.8456302","article-title":"Heterologous protection against influenza by injection of DNA encoding a viral protein","volume":"259","author":"Ulmer","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2008.04.058_bib2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0065-3527(08)60367-X","article-title":"DNA vaccines: a review","volume":"54","author":"Lewis","year":"1999","journal-title":"Adv Virus Res"},{"key":"10.1016\/j.vaccine.2008.04.058_bib3","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1023\/A:1011950415325","article-title":"Genetic vaccines: strategies for optimisation","volume":"15","author":"Gregoriadis","year":"1998","journal-title":"Pharm Res"},{"key":"10.1016\/j.vaccine.2008.04.058_bib4","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1089\/hum.1993.4.2-151","article-title":"Direct gene transfer in skeletal muscle in vivo: factors influencing efficiency of transfer and stability of expression","volume":"4","author":"Davis","year":"1993","journal-title":"Human Gene Ther"},{"key":"10.1016\/j.vaccine.2008.04.058_bib5","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/356152a0","article-title":"Genetic immunization is a simple method for eliciting an immune response","volume":"356","author":"Tang","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2008.04.058_bib6","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.4049\/jimmunol.160.12.5707","article-title":"Specific immune induction following DNA-based immunization through in vivo transfection and activation of macrophages: antigen presenting cells","volume":"160","author":"Chattergon","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2008.04.058_bib7","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1089\/aid.1997.13.1421","article-title":"Cationic liposomes are a strong adjuvant for a DNA vaccine of human immunodeficiency virus type 1","volume":"13","author":"Ishii","year":"1997","journal-title":"Aids Res Human Retrovirus"},{"key":"10.1016\/j.vaccine.2008.04.058_bib8","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1021\/bc9701048","article-title":"Nanoparticle DNA carrier with poly(l-lysine) grafted polysaccharide co-polymer and poly(d,l-lactic acid)","volume":"8","author":"Maruyama","year":"1997","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.vaccine.2008.04.058_bib9","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.progpolymsci.2005.01.007","article-title":"Birth of a new macromolecular architecture: dendrimers as quantized building blocks for nanoscale synthetic polymer chemistry","volume":"30","author":"Tomalia","year":"2005","journal-title":"Prog Polym Sci"},{"key":"10.1016\/j.vaccine.2008.04.058_bib10","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S1461-5347(99)00203-5","article-title":"Designing dendrimers for drug delivery","volume":"2","author":"Liu","year":"1999","journal-title":"Pharm Sci Technol Today"},{"key":"10.1016\/j.vaccine.2008.04.058_bib11","first-page":"15","article-title":"Dendrimer polycations for delivery of genes","volume":"65","author":"Tripathi","year":"2003","journal-title":"Indian J Pharm Sci"},{"key":"10.1016\/j.vaccine.2008.04.058_bib12","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1021\/cr9603892","article-title":"Dendrimers in supramolecular chemistry; from molecular recognition to self-assembly","volume":"97","author":"Zeng","year":"1997","journal-title":"Chem Rev"},{"key":"10.1016\/j.vaccine.2008.04.058_bib13","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1093\/nar\/24.11.2176","article-title":"Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers","volume":"24","author":"Bielinska","year":"1996","journal-title":"Nucleic Acid Res"},{"key":"10.1016\/j.vaccine.2008.04.058_bib14","first-page":"180","article-title":"The interaction of plasmid DNA with polyamidoamine dendrimers; mechanism of complex formation and analysis of alternations induced in nuclear sensitivity and transcriptional activity of the complexed DNA","volume":"1353","author":"Bielinska","year":"1997","journal-title":"Biochem Biophys Acta"},{"key":"10.1016\/j.vaccine.2008.04.058_bib15","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/sj.gt.3300867","article-title":"Metabolic stability of plasmid DNA in the cytosol: a potential barrier to gene transfer","volume":"6","author":"Lechardeur","year":"1999","journal-title":"Gene Ther"},{"key":"10.1016\/j.vaccine.2008.04.058_bib16","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1089\/104303401750195836","article-title":"Non-viral vectors in the new millennium: delivery barriers in gene transfer","volume":"12","author":"Nishikawa","year":"2001","journal-title":"Hum Gene Ther"},{"issue":"2","key":"10.1016\/j.vaccine.2008.04.058_bib17","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/17458080600647146","article-title":"Dendrosome based gene delivery","volume":"1","author":"Dutta","year":"2006","journal-title":"J Exp Nanosci"},{"key":"10.1016\/j.vaccine.2008.04.058_bib18","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3109\/10611869609015966","article-title":"High yield incorporation of plasmid DNA within liposomes: effect on DNA intergrity and transfection","volume":"3","author":"Gregoriadis","year":"1996","journal-title":"J Drug Target"},{"key":"10.1016\/j.vaccine.2008.04.058_bib19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0005-2760(95)00208-1","article-title":"Morphological observations on the fate of liposomes in the regional lymph nodes after footpad injection into rats","volume":"1299","author":"Velinova","year":"1996","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.vaccine.2008.04.058_bib20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0304-4165(83)90132-0","article-title":"Fate of cholesterol rich unilamellar liposomes containing 111-I-labelled bleomycin after subcutaneous injection into rats","volume":"760","author":"Tumer","year":"1983","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.vaccine.2008.04.058_bib21","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1016\/S0264-410X(00)00432-1","article-title":"Liposome-mediated DNA vaccination: the effect of vesicle composition","volume":"19","author":"Perrie","year":"2001","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2008.04.058_bib22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/10611860600965914","article-title":"Poly(propyleneimine) dendrimer based nanocontainers for targeting of efavirenz to human monocytes\/macrophages in vitro","volume":"15","author":"Dutta","year":"2007","journal-title":"J Drug Target"},{"issue":"a","key":"10.1016\/j.vaccine.2008.04.058_bib23","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1002\/anie.199313081","article-title":"Poly(propylene) imine dendrimers: large scale synthesis by heterogeneously catalyzed hydrogenation","volume":"32","author":"De Brabender Van Den Berg","year":"1993","journal-title":"Angew Chem Int Ed Eng"},{"key":"10.1016\/j.vaccine.2008.04.058_bib24","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1089\/hum.1998.9.4-553","article-title":"Efficient transfer of genes into murine cardiac graft by starburst PAMAM dendrimers","volume":"9","author":"Qin","year":"1998","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.vaccine.2008.04.058_bib25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0168-3659(99)00246-1","article-title":"Dendrimers relationship between structure and biocompatibility in vitro and preliminary studies on biodistribution of 125I labeled polyamidoamine dendrimers in vivo","volume":"65","author":"Malik","year":"2000","journal-title":"J Control Rel"},{"issue":"1\/2","key":"10.1016\/j.vaccine.2008.04.058_bib26","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0378-5173(02)00623-3","article-title":"The influence of surface modification on the cytotoxicity of PAMAM dendrimers","volume":"252","author":"Jevprasesphant","year":"2003","journal-title":"Int J Pharm"},{"key":"10.1016\/j.vaccine.2008.04.058_bib27","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1128\/IAI.60.2.523-528.1992","article-title":"Endogenous tumor necrosis factor, interleukin-6, and gamma interferon levels during Listeria monocytogenes infection in mice","volume":"60","author":"Nakane","year":"1992","journal-title":"Infect Immunol"},{"key":"10.1016\/j.vaccine.2008.04.058_bib28","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1128\/IAI.64.9.3532-3536.1996","article-title":"Cytokines and antibody subclass associated with protective immunity against blood-stage malaria in mice vaccinated with the C terminus of merozoite surface protein 1 plus a novel adjuvant","volume":"64","author":"de Souza","year":"1996","journal-title":"Infect Immunol"},{"key":"10.1016\/j.vaccine.2008.04.058_bib29","first-page":"1553","article-title":"CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice","volume":"95","author":"Brazolot Millan","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2008.04.058_bib30","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1042\/bst0040253a","article-title":"Interaction of liposomes with blood plasma proteins","volume":"4","author":"Black","year":"1976","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.vaccine.2008.04.058_bib31","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0304-4165(00)00055-6","article-title":"Liposome-entrapped plasmid DNA: characterisation studies","volume":"1475","author":"Perrie","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.vaccine.2008.04.058_bib32","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3109\/08982109709035480","article-title":"Cationic liposomes as an oligonucleotide carrier: mechanism of action","volume":"7","author":"Zelphati","year":"1996","journal-title":"J Liposome Res"},{"key":"10.1016\/j.vaccine.2008.04.058_bib33","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0014-5793(96)01507-4","article-title":"Liposome-mediated DNA vaccination","volume":"402","author":"Gregoriadis","year":"1997","journal-title":"FEBS Lett"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08005252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08005252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T08:47:33Z","timestamp":1684399653000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08005252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":33,"journal-issue":{"issue":"27-28","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0264410X08005252"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.04.058","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}